The Effect of Moderate Weight Loss on a Non-Invasive Biomarker of Liver Fibrosis: A Randomised Controlled Trial

BACKGROUND: Referral to weight loss programmes is the only effective treatment for non-alcoholic fatty liver disease (NAFLD). Clinicians should advise weight loss and screen for liver fibrosis using the Enhanced Liver Fibrosis (ELF) score. AIM: To examine if the ELF score changes with weight loss. D...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Obes Facts
Asıl Yazarlar: Koutoukidis, Dimitrios A., Jebb, Susan A., Aveyard, Paul, Astbury, Nerys M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: S. Karger AG 2020
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7250344/
https://ncbi.nlm.nih.gov/pubmed/32200381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000505667
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller